Efficacy of Probiotic Treatment as Post-Exposure Prophylaxis for COVID-19: A Double-Blind, Placebo-ControlledRandomized Trial

The COVID-19 pandemic continues to pose unprecedented challenges to worldwide health. While vaccines are effective, additional strategies to mitigate the spread/severity of COVID-19 continue to be needed. Emerging evidence suggests susceptibility to respiratory tract infections in healthy subjects can be reduced by probiotic interventions; thus, probiotics may be a low-risk, low-cost, and easily implementable modality to reduce risk of COVID-19.

Source: Clinical Nutrition - December 11, 2023 Category: Nutrition Authors: Paul E. Wischmeyer, Helen Tang, Yi Ren, Lauren Bohannon, Danting Jiang, Matthew Bergens, Zeni E. Ramirez, Tessa M. Andermann, Julia A. Messina, Julia A. Sung, David Jensen, Sin-Ho Jung, Alexandra Artica, Anne Britt, Amy Bush, Ernaya Johnson, Meagan V. Lew Tags: Randomized Control Trials Source Type: research